We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management port...
Streamlining Healthcare Delivery Through Digital Care Journeys with Dr. Joshua Liu, Co-founder & CEO of SeamlessMD
Dr. Joshua Liu, Co-founder & CEO of SeamlessMD, explores how technology and “Digital Care Journeys” can help hospitals reduce the surgical backlog for high-volume procedures like hip and knee replacements, the evolution of healthcare delivery, and more.Connect with Dr. Joshua Liu:https://www.linkedin.com/in/joshuapliu/ https://seamless.md/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity. Click the social media buttons to share this episode with your network! To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: Home Page LinkedIn: https://www.linkedin.com/company/impetus-digital/ Twitter: impetus_digital YouTube: Impetus Digital
--------
39:43
Diversifying Healthcare AI with Federated Learning with Dr. Ittai Dayan, Co-founder & CEO of Rhino Health
Dr. Ittai Dayan, Co-founder & CEO of Rhino Health, shares how his company is transforming the way healthcare AI solutions are created, adopted and measured. He will also explore how to create equitable access to advanced AI-based diagnostics and treatment pathways, how biopharma companies can leverage federated learning to overcome the challenges of accessing real-world data, and more.Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity. Click the social media buttons to share this episode with your network! To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: Home Page LinkedIn: https://www.linkedin.com/company/impetus-digital/ Twitter: impetus_digital YouTube: Impetus Digital
--------
34:37
Repurposing Off-Patent Drugs Through Crowd Funding with Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures
Savva Kerdemelidis, Founder & CEO of Crowd Funded Cures, explores the concepts of interventional pharmacoeconomics and pay-for-success contracts to fund new uses for off-patent drugs and other unmonopolizable therapies. Savva Kerdemelidis: https://www.linkedin.com/in/savvak/Crowd Funded Cures: https://crowdfundedcures.org/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity. Click the social media buttons to share this episode with your network! To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: Home Page LinkedIn: https://www.linkedin.com/company/impetus-digital/ Twitter: impetus_digital YouTube: Impetus Digital
--------
43:59
How the Legally Blind Can Achieve Enhanced Vision with Roland Mattern, Director of Product Marketing at eSight Eyewear
Roland Mattern, Director of Product Marketing at eSight Eyewear, shares how eSight’s technologies are being used to bring sight back to people living with central vision loss. He also discusses key learnings from his 30-year career in the pharma and medical device sectors, his predictions and hopes for the future of ‘smart eyewear,’ and more.Roland Mattern: https://www.linkedin.com/in/roland-mattern-777a585/eSight Eyewear: https://esighteyewear.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity. Click the social media buttons to share this episode with your network! To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: Home Page LinkedIn: https://www.linkedin.com/company/impetus-digital/ Twitter: impetus_digital YouTube: Impetus Digital
--------
41:54
Streamlining Cardiac Care with Real Time Monitors with Dr. Waqaas Al-Siddiq, Founder & CEO of Biotricity
Dr. Waqaas Al-Siddiq, Founder & CEO of Biotricity, explores his journey from computer engineering to healthcare, innovation in the cardiac monitoring space, the concept of Mobile Cardiac Telemetry (MCT), and more.To find out more about Impetus: https://www.meetwithimpetus.comNatalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/Impetus Digital Website: https://www.impetusdigital.com/Impetus Digital LinkedIn: https://www.linkedin.com/company/impetus-digital/Impetus Digital Twitter: https://twitter.com/impetus_digitalImpetus YouTube: https://www.youtube.com/ImpetusDigitalDr. Waqaas Al-Siddiq: https://www.linkedin.com/in/dr-waqaas-al-siddiq-dba-5a0b682/Biotricity: https://www.biotricity.com/Impetus Digital has been delivering best-in-class virtual and hybrid meetings, events, and programs for global life science companies since 2008. We work closely with clinical, market access, medical affairs, marketing, medical education, and many other departments to virtualize their internal and external stakeholder meetings, such as advisory boards, learning programs, working groups, and congress engagement initiatives. We partner with clients at all stages of the product life cycle, from R&D to loss of exclusivity. Click the social media buttons to share this episode with your network! To learn more about Impetus, our services, and our tools: https://www.meetwithimpetus.com Natalie Yeadon LinkedIn: https://www.linkedin.com/in/natalieyeadon/ Impetus Digital Website: Home Page LinkedIn: https://www.linkedin.com/company/impetus-digital/ Twitter: impetus_digital YouTube: Impetus Digital
We are covering topics on tissue 3D bioprinting, clinical trials in silica, quantum computing in product development, blockchain-powered patient management portals, nanotechnologies, and digital therapeutics. We are also covering topics on leadership in the new pharma paradigm post-COVID-19 and what it will mean to function in the new virtual world we find ourselves in. We will be asking how pharma business models will need to change and what new partnerships will need to develop as a result of this pandemic. At Impetus Digital, we believe all new, great ideas start with a conversation. Building on each other's ideas over time. One step at a time. This is how we believe positive disruption will occur. At Impetus Digital, we are leaders in delivering virtual collaboration experiences for life sciences companies. We offer the most comprehensive virtual meeting and event tools and services on the market. The Impetus InSite Platform® is a turn-key software solution that enables a “long-game” approach in connecting brands with key stakeholders, both synchronously and asynchronously. Its customizable, multilingual interface and its robust, pharma-compliant security make it the ideal choice for authentic engagement. Founded in 2008, we have over a decade of experience in virtualizing meetings and events. We offer a full range of strategic, medical writing, and digital services to help make the transition to hybrid events seamless. Visit our website www.impetusdigital.com to learn more!
New Zealand